Biotech, medical device, and pharmaceutical company pioneers are represented by Schwabe.

industry relationships

Defence Research Institute (DRI) Product Liability Committee

Oregon Health and Sciences University

Oregon Bioscience Association

Association of University Technology Managers

What our clients say

‎”Schwabe has excellent patent attorneys, with outstanding technical depth and great business acumen, which ‎helps us make smart business decisions. Their work for us has always been high quality and their team has ‎consistently been available for time-sensitive issues. I strongly recommend the entire Schwabe team for ‎sophisticated IP work.”‎

Andrew Barofsky, President and CEO, RevMedx, Inc.


  • Defended against pharmaceutical and medical device claims for over 40 ‎years, representing manufacturers in individual cases, mass tort ‎litigation, and class action lawsuits.‎
  • Represent branded pharmaceutical companies in the preparation and prosecution of patent applications in the US and abroad directed to biopharmaceutical products including antibodies, bispecific and multispecific antigen-binding molecules, fusion proteins, chimeric antigen receptors, and AAVs, as well as formulations, and purification and characterization processes and assays.
  • Represent a research institution in the preparation and prosecution of patent applications directed to medical devices, diagnostics, therapeutics, drug delivery, and imaging.
  • Defended a medical device developer in multibillion-dollar infringement lawsuits. The favorable outcome included “exceptional case” determination and fee awards for our clients. 

  • Defended a global pharmaceutical manufacturer against product defect claims based upon novel “innovator liability” theory.

  • Represent research institutions, major universities, and medical schools in the preparation and prosecution of patent applications involving technologies ranging from medical ‎devices to diagnostics/assays to treatments to biochemical and pharmaceutical innovations.‎
  • Successfully defended a closely held company before the Oregon District Court in a patent infringement suit launched by a global medical device company, obtaining the reversal of an $85 million jury verdict against our client. 
  • Representing medical device manufacturer in competitor patent litigation involving partially implantable continuous glucose monitoring (CGM) sensor system for diabetes patients.
  • Represented medical device manufacturer in multiple competitor patent litigations regarding transducers, medical monitor design, and intravascular guide wire design.
  • Led the defense of a large generic pharmaceutical company in multiple patent suits brought by owners of branded pharmaceutical products under the Hatch-Waxman Act.
  • Obtained summary judgment of non-infringement for a large medical device company accused of infringing patents directed to a genetically modified reverse transcriptase.

Sign up

Ideas & Insights